The global geriatric medicine market size is expected to reach USD 260.0 billion by 2030, registering a CAGR of 7.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increase in the global geriatric population is one of the major challenges for the healthcare industry and the governments across the globe, however, it has proven to be a boon for the...

The global multiple myeloma therapeutics market size was estimated at USD 20.87 billion in 2023 and is projected to reach USD 30.30 billion by 2030, growing at a CAGR of 5.5% from 2024 to 2030. This growth is primarily driven by ongoing research and development efforts by key pharmaceutical companies, regulatory approvals from health authorities, and the launch of new therapies and...

RNA Analysis Market Projected to Reach USD 34.37 Billion by 2032 RNA analysis market, valued at USD 9.58 billion in 2022, is anticipated to reach USD 34.37 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 14% during the forecast period. Market Definition and Estimation RNA analysis, also known as transcriptomics, involves the study of the transcriptome—the complete...

US Multiple Myeloma Therapeutics Market size was valued at USD 3.8 Bn. in 2023 and the total US Multiple Myeloma Therapeutics revenue is expected to grow at a CAGR of 2.8 % from 2024 to 2030, reaching nearly USD 4.61 Bn. in 2030. US Multiple Myeloma Therapeutics Market Overview Stellar Market Research, anUS Multiple Myeloma Therapeutics business research firm has published a...

The US Multiple Myeloma Therapeutics Market size was valued at USD 3.8 Bn. in 2023 and the total US Multiple Myeloma Therapeutics revenue is expected to grow at a CAGR of 2.8 % from 2024 to 2030, reaching nearly USD 4.61 Bn. in 2030. US Multiple Myeloma Therapeutics Market Overviews Stellar Market Research is an US Multiple Myeloma Therapeutics Market research company, that has published...

US Multiple Myeloma Therapeutics Market size was valued at USD 3.8 Bn. in 2023 and the total US Multiple Myeloma Therapeutics revenue is expected to grow at a CAGR of 2.8 % from 2024 to 2030, reaching nearly USD 4.61 Bn. in 2030. US Multiple Myeloma Therapeutics Market Overview The report analyzed by Stellar Market Research, on the market, covers an extensive regional analysis and...